ロード中...
Inhibition of the hexosamine biosynthesis pathway potentiates cisplatin cytotoxicity by decreasing BiP expression in non-small cell lung cancer cells
Platinum anticancer agents are essential components in chemotherapeutic regimens for non-small cell lung cancer (NSCLC) patients ineligible for targeted therapy. However, platinum-based regimens have reached a plateau of therapeutic efficacy; therefore, it is critical to implement novel approaches f...
保存先:
| 出版年: | Mol Carcinog |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6525013/ https://ncbi.nlm.nih.gov/pubmed/30790354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.22992 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|